Cathie Wood, of ARK Genomic Revolution ETF(NYSE: ARKG) explains the multi-trillion dollar opportunity in the Genomics Revolution: CAR-T, CRISPR, and DNA Sequencing
The $TRILLION Opportunity in CRISPR & DNA Sequencing Technologies
Commodities
Uranium: How to Know When the Bull Market Really Starts
Gwen Preston explains the current uranium pricing and market fundamentals and how to tell when the market is about to explode upwards. Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for […]
Healthcare
CytoDyn’s (OTC: CYDY) Leronlimab (PRO 140) reduces by more than 98% human breast cancer metastasis in mouse xenografts for over 6 weeks
Based on strong results in its pre-clinical animal study, CytoDyn files for Orphan Drug Designation for Triple-Negative Breast Cancer VANCOUVER, Washington, Feb 20, 2019 – CytoDyn Inc. (otc.qb:CYDY), a biotechnology company developing a novel humanized […]
Healthcare
CytoDyn (OTC: CYDY) to Present at RHK Capital 2019 Disruptive Growth Conference
VANCOUVER, Washington, Aug. 29, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]